日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Brazil's response to public health emergencies in 2023: lessons for the international community

巴西应对2023年公共卫生突发事件的措施:对国际社会的启示

de Souza, Ana Sara Semeão; Cavalcante, João Roberto; Proença, Raquel; Frank, Carlos Henrique Michiles; Mendonça, Thiago Basílio; Costacurta, Giovana Ferreira; de Assis Rodrigues, Igor; da Fonseca, José Lucas Pinho; de Freitas, Daniel Roberto Coradi; Filho, Edenilo Baltazar Barreira; Maciel, Ethel Leonor Noia; de Oliveira Garcia, Márcio Henrique

Modified palatal flap via soft palate for skull base reconstruction

经软腭改良腭瓣法重建颅底

Pezato, Rogerio; Stamm, Aldo Cassol; Costacurta, Andrea Santos Dumont; Baptista, Carlos Henrique Amaro Bravo; Fujita, Reginaldo Raimundo; Dassi, Camila Soares; Voegels, Richard Louis; Thamboo, Andrew; Tepedino, Miguel Soares

Using Vesicular Stomatitis Virus as a Platform for Directed Protease Evolution.

利用水疱性口炎病毒作为平台进行定向蛋白酶进化

Costacurta Francesco, Rauch Stefanie, von Laer Dorothee, Heilmann Emmanuel

A proposal for analyzing the inflammatory and remodeling processes of mucosa in chronic rhinosinusitis with nasal polyposis through MRI

利用磁共振成像技术分析慢性鼻窦炎伴鼻息肉患者黏膜炎症和重塑过程的提案

Garcez, Débora de Carvalho; Tepedino, Miguel Soares; Migueis, Debora Petrungaro; Vianna, Pedro Miño; Costacurta, Andrea Santos Dumont; Portari, Elyzabeth Avvad; Messeder, Alexandre Malta da Costa; Voegels, Richard Louis; Boggi, Alexandre Coelho; Fujita, Reginaldo Raimundo; Thamboo, Andrew; Pezato, Rogério

Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir

MERS-CoV 和 SARS-CoV-2 主要蛋白酶中关键残基对临床应用抑制剂尼玛瑞韦和恩西瑞韦耐药性的研究

Laura Krismer, Helge Schöppe #, Stefanie Rauch #, David Bante, Bernhard Sprenger, Andreas Naschberger, Francesco Costacurta, Anna Fürst, Anna Sauerwein, Bernhard Rupp, Teresa Kaserer, Dorothee von Laer, Emmanuel Heilmann

Vesicular Stomatitis Virus as a Platform for Protease Activity Measurements

水泡性口炎病毒作为蛋白酶活性测量的平台

Stefanie Rauch, Francesco Costacurta, Dorothee von Laer, Emmanuel Heilmann

SARS-CoV-2 3CLpro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376

在基于 VSV 的系统中筛选出的 SARS-CoV-2 3CLpro 突变导致对尼玛瑞韦、恩西瑞韦和 GC376 产生耐药性

Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, Chengjin Ye, Matteo Pavan, Davide Bassani, Andre Volland, Claudia Ascher, Alexander Kurt Hermann Weiss, David Bante, Reuben S Harris, Stefano Moro, Bernhard Rupp, Luis Martinez-Sobrido, Dorothee von Laer

Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors

对临床蛋白酶抑制剂具有耐药性的可传播 SARS-CoV-2 变体

Seyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, Christina Nnabuife, Fiona L Kearns, Chengjin Ye, Sofia N Moraes, Francesco Costacurta, Morgan A Esler, Hideki Aihara, Dorothee von Laer, Luis Martinez-Sobrido, Timothy Palzkill, Rommie E Amaro, Reuben S Harris

Linking Migraine to Gut Dysbiosis and Chronic Non-Communicable Diseases

将偏头痛与肠道菌群失调和慢性非传染性疾病联系起来

Di Lauro, Manuela; Guerriero, Cristina; Cornali, Kevin; Albanese, Maria; Costacurta, Micaela; Mercuri, Nicola Biagio; Di Daniele, Nicola; Noce, Annalisa

A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition

基于 VSV 的检测方法可量化冠状病毒 Mpro/3CLpro/Nsp5 主要蛋白酶活性和化学抑制

Emmanuel Heilmann, Francesco Costacurta #, Stephan Geley #, Seyad Arad Mogadashi #, Andre Volland #, Bernhard Rupp, Reuben Stewart Harris, Dorothee von Laer